INTERMITTENT TOPICAL TREATMENT OF PSORIASIS WITH BETAMETHASONE DIPROPIONATE 0.05 PERCENT CREAM

被引：0

作者：

VANDIJK, E

BAKKERS, EJM

GO, MJ

MONTNOR, LP

ROESSEL, FE

VANDERWATEREN, AR

WUITE, J

机构：

[1] DIACONESSENHUIS, DEPT DERMATOL, NAARDEN, NETHERLANDS

[2] DE WEVER HOSP, DEPT DERMATOL, HEERLEN, NETHERLANDS

[3] ST LAMBERTUS HOSP, DEPT DERMATOL, HELMOND, NETHERLANDS

[4] AMSTELVEEN HOSP, DEPT DERMATOL, HAARLEM, NETHERLANDS

[5] MARIA STICHTING HOSP, DEPT DERMATOL, HAARLEM, NETHERLANDS

来源：

CUTIS | 1983年 / 32卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：284 / +

页数：1

共 50 条

[41] DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis
Fowler, Joseph E., Jr.
Hebert, Adelaide A.
Sugarman, Jeffrey
JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (02) : 154 - 162
[42] TREATMENT OF ATOPIC-DERMATITIS IN CHILDREN - ALCLOMETASONE DIPROPIONATE CREAM 0.05-PERCENT VERSUS HYDROCORTISONE BUTYRATE CREAM 0.1-PERCENT
KINT, A
ACTA THERAPEUTICA, 1987, 13 (05) : 455 - 468
[43] EFFICACY OF A BETAMETHASONE DIPROPIONATE TOPICAL GLYCOL PREPARATION IN THE MANAGEMENT OF SEVERE PSORIASIS
LEER, JA
CLINICAL THERAPEUTICS, 1980, 3 (03) : 156 - 167
[44] Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis
Dauden, E.
Bewley, A.
Lambert, J.
Girolomoni, G.
Cambazard, F.
Reich, K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 : 22 - 32
[45] INDUCTION OF GENERALIZED PUSTULAR PSORIASIS BY TOPICAL USE OF BETAMETHASONE-DIPROPIONATE OINTMENT IN PSORIASIS
HELLGREN, L
ANNALS OF CLINICAL RESEARCH, 1976, 8 (05): : 317 - 319
[46] Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis
Amat-Samaranch, Victoria
Puig, Lluis
EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 423 - 432
[47] AMCINONIDE VS BETAMETHASONE DIPROPIONATE OINTMENTS IN THE TREATMENT OF PSORIASIS
HUNTLEY, AC
ISSEROFF, R
CUTIS, 1985, 35 (05): : 489 - 492
[48] CLINICAL COMPARISON OF ALCLOMETASONE DIPROPIONATE CREAM 0.05-PERCENT WITH HYDROCORTISONE BUTYRATE CREAM 0.1-PERCENT IN THE TREATMENT OF ATOPIC-DERMATITIS IN CHILDREN
LASSUS, A
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1983, 11 (05) : 315 - 319
[49] COMPARISON OF THE BIOACTIVITY OF MOMETASONE FUROATE 0.1-PERCENT FATTY CREAM, BETAMETHASONE DIPROPIONATE 0.05-PERCENT CREAM AND BETAMETHASONE VALERATE 0.1-PERCENT CREAM IN HUMANS - INHIBITION OF UV-B-INDUCED INFLAMMATION MONITORED BY LASER-DOPPLER BLOOD FLOWMETRY
BJERRING, P
SKIN PHARMACOLOGY, 1993, 6 (03): : 187 - 192
[50] COMPARATIVE-STUDIES OF AUGMENTED BETAMETHASONE DIPROPIONATE LOTION 0.05-PERCENT AND CLOBETASOL PROPIONATE SOLUTION 0.05-PERCENT - CORRELATION OF THE VASOCONSTRICTION ASSAY AND CLINICAL ACTIVITY IN SCALP PSORIASIS
JARRATT, M
DAVIS, JG
GILTNER, MP
JONES, ML
PEETS, EA
ADVANCES IN THERAPY, 1991, 8 (02) : 103 - 111

← 1 2 3 4 5 →